ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,851.70
-0.15%
S&P ASX All Technology
3,077.90
0.70%
Brent Oil
83.02
-0.61%
US Dollar vs AUD
1.50229
0.23%
Bitcoin
71,054.98
-0.55%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Amryt Pharma Plc (AMYT)

  7. Amryt Pharma Plc (AMYT) News

AMYT

Amryt Pharma (AMYT)

Amryt Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AMYT
DateTimeSourceHeadlineSymbolCompany
12/01/202201:39Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma delists from AIM as trading shifts to New YorkLSE:AMYTAmryt Pharma Plc
07/01/202204:29UK RegulatoryFTSE Russell Amryt PharmaLSE:AMYTAmryt Pharma Plc
06/01/202218:00UK RegulatoryAmryt Pharma plc Key Dates For Aim DelistingLSE:AMYTAmryt Pharma Plc
04/01/202223:00UK RegulatoryAmryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly PatientsLSE:AMYTAmryt Pharma Plc
04/01/202218:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
01/12/202118:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
30/11/202118:00UK RegulatoryAmryt Pharma plc Director/Pdmr ShareholdingLSE:AMYTAmryt Pharma Plc
24/11/202100:21Dow Jones NewsAmryt Pharma Says FDA Extends Oleogel-S10 New Drug Application Review by Three MonthsLSE:AMYTAmryt Pharma Plc
23/11/202123:00UK RegulatoryAmryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10LSE:AMYTAmryt Pharma Plc
22/11/202118:00UK RegulatoryAmryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On AimLSE:AMYTAmryt Pharma Plc
10/11/202109:01Alliance NewsAlliance NewsTRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pillLSE:AMYTAmryt Pharma Plc
03/11/202122:00UK RegulatoryAmryt Pharma plc Amryt Reports Strong Q3 2021 ResultsLSE:AMYTAmryt Pharma Plc
02/11/202100:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
01/11/202118:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Acromegaly Awareness DayLSE:AMYTAmryt Pharma Plc
22/10/202117:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global EB Awareness Week 2021LSE:AMYTAmryt Pharma Plc
20/10/202122:00UK RegulatoryAmryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3LSE:AMYTAmryt Pharma Plc
19/10/202122:00UK RegulatoryAmryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)LSE:AMYTAmryt Pharma Plc
01/10/202116:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
23/09/202120:59RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global FH Awareness DayLSE:AMYTAmryt Pharma Plc
14/09/202116:32Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisitionLSE:AMYTAmryt Pharma Plc
13/09/202121:00UK RegulatoryAmryt Pharma plc Amryt Raises Full Year 2021 Revenue Guidance To $220m - $225mLSE:AMYTAmryt Pharma Plc
01/09/202116:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
19/08/202116:00UK RegulatoryAmryt Pharma plc Amryt Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
13/08/202122:23UK RegulatoryAmryt Pharma PLC Holding(s) in Company - ReplacementLSE:AMYTAmryt Pharma Plc
11/08/202120:30UK RegulatoryAmryt Pharma PLC Holdings in CompanyLSE:AMYTAmryt Pharma Plc
11/08/202119:36UK RegulatoryAmryt Pharma PLC Holding(s) in CompanyLSE:AMYTAmryt Pharma Plc
10/08/202123:20UK RegulatoryAmryt Pharma plc Director/Pdmr ShareholdingLSE:AMYTAmryt Pharma Plc
10/08/202118:53UK RegulatoryAmryt Pharma PLC Holding(s) in CompanyLSE:AMYTAmryt Pharma Plc
09/08/202121:00UK RegulatoryAmryt Pharma plc Amryt Virtual Capital Markets Event - September 13, 2021 -- 1000-1200 EdtLSE:AMYTAmryt Pharma Plc
06/08/202123:41Alliance NewsAlliance NewsIN BRIEF: Amryt hikes guidance on record second quarter resultsLSE:AMYTAmryt Pharma Plc
 Showing the most relevant articles for your search:LSE:AMYT

Your Recent History

ASX
TLS
Telstra
NYSE
VZ
Verizon Communications
NASDAQ
NVDA
NVIDIA
ASX
SUN
Suncorp
NYSE
XOM
Exxon Mobil
FTSE
UKX
FTSE 100
NYSE
JPM
JP Morgan Chase
FX
AUDCAD
AUD vs CAD
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
ASX
XMM
S&P ASX 300 Metals and M...
ASX
BHP
BHP
ASX
XJO
S&P ASX 200
NASDAQ
AMZN
Amazon.com
ASX
NAB
National Australia Bank
ASX
CSL
CSL
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved